New Zealand markets closed

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
147.66+11.86 (+8.73%)
At close: 04:00PM EDT
146.90 -0.76 (-0.51%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close135.80
Open137.38
Bid146.90 x 1200
Ask147.00 x 1100
Day's range136.59 - 148.54
52-week range119.01 - 497.49
Volume7,540,876
Avg. volume6,875,373
Market cap58.733B
Beta (5Y monthly)1.70
PE ratio (TTM)4.34
EPS (TTM)34.02
Earnings date03 Aug 2022 - 08 Aug 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est220.00
  • Motley Fool

    Why Moderna Stock Is Jumping Today

    Shares of Moderna (NASDAQ: MRNA) were jumping 7.5% higher as of 11:30 a.m. ET on Friday. Instead, Moderna appears to be benefiting from the overall stock market bounce. Good news for the overall stock market tends to be good news for Moderna.

  • Motley Fool

    Knowing This Number Can Save Your Portfolio From Disaster

    The S&P 500 has fallen by 17% since the start of the year, the Nasdaq Composite is down by almost 28%, and many popular growth stocks have been struggling, including big names like Tesla (NASDAQ: TSLA) and Moderna (NASDAQ: MRNA), which have performed even worse than the indexes. Beta is a measure of an investment's volatility based on how closely its performance mirrors that of the broader market. If a stock's beta value is greater than 1, it has in the past exhibited wider swings than the market -- and you can generally expect that it will continue to do so.

  • Motley Fool

    Better Buy Ahead of FDA Meetings: Moderna vs. Novavax

    Moderna (NASDAQ: MRNA) and Novavax (NASDAQ: NVAX) both delivered major returns for investors in the early days of the coronavirus vaccine race. Moderna's vaccine entered the market in December of 2020. Novavax's vaccine began winning authorizations a year later -- but isn't yet approved in the United States.